ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Michigan » Specialist

Top Specialist Prescribers in Michigan

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
FILOMENA BUENAFLOR M.D.

Specialist

3,854

$272K

192
182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $104

SATISH SOLANKI M.D.

Specialist

3,629

$317K

433
286 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

39%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 24%

$87
Average prescription price

Avg: $104

ALLEN BALINSKI MD

Specialist

3,610

$179K

264
149 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $104

JEFFREY ROSENBERG MD, PHD

Specialist

3,605

$322K

231
80 are 65+

62%
patients receiving schedule two controlled substances

Avg: 5%

47%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$89
Average prescription price

Avg: $104

GHAZALA ZAFAR M.D.

Specialist

3,597

$185K

261
224 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $104

CATHY GLICK MD

Specialist

3,590

$194K

510
446 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $104

AARON BERMAN M.D.

Specialist

3,364

$315K

350
328 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$94
Average prescription price

Avg: $104

DOUGLAS WESTVEER M.D.

Specialist

3,348

$335K

347
315 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 24%

$100
Average prescription price

Avg: $104

SAMUEL JONNALAGADDA MD

Specialist

3,340

$198K

235
178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $104

JOSEPH NAOUM MD

Specialist

3,254

$242K

392
363 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$74
Average prescription price

Avg: $104

HEMA TALASILA M.D..

Specialist

2,924

$290K

250
111 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$99
Average prescription price

Avg: $104

RAMACHANDRA VEMURI M.D.

Specialist

2,889

$140K

178
125 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $104

MAZEN SHOUKFEH M.D.

Specialist

2,842

$306K

365
323 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 24%

$108
Average prescription price

Avg: $104

MANJIT GREWAL M.D.

Specialist

2,768

$278K

402
311 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$100
Average prescription price

Avg: $104

MARK BERNSTEIN MD

Specialist

2,762

$231K

376
348 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $104

DAVID VERDIER M.D.

Specialist

2,751

$111K

825
769 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

1%
patients receiving schedule three controlled substances

Avg: 16%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

63%
prescriptions for brand name drugs

Avg: 24%

$40
Average prescription price

Avg: $104

A LERNER M.D.

Specialist

2,730

$745K

128
90 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$273
Average prescription price

Avg: $104

SAMIR YAHIA M.D.

Specialist

2,636

$314K

247
151 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

37%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 24%

$119
Average prescription price

Avg: $104

SYAMASUNDERA ZAMPANI MD

Specialist

2,631

$142K

323
302 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $104

CORNELIUS ROBENS M.D.

Specialist

2,626

$991K

339
214 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$377
Average prescription price

Avg: $104

MARK ZANDE MD

Specialist

2,591

$137K

424
364 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $104

LUBNA AHSAN MD

Specialist

2,507

$137K

166
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

27%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $104

ERIC BATTS M.D.

Specialist

2,505

$1.98M

384
318 are 65+

15%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$789
Average prescription price

Avg: $104

SERGIO PONZE M.D.

Specialist

2,483

$278K

314
232 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$112
Average prescription price

Avg: $104

TONYA SEXTON D.O.

Specialist

2,459

$112K

151
111 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $104

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank